Healthcare - Page 1 | TalkMarkets
All Posts > Content under Healthcare
1 to 16 of 4117 Posts
1 2 3 ... 258
Corbus Moves Lead Candidate To Phase 3 Study, Offers Good Investment Deal
Article By: KKD Healthcare Analytics
Thursday, June 22, 2017 9:33 AM EDT
Corbus has several catalysts coming up as it progresses with the testing of its lead drug candidate for different indications. Its earliest upcoming catalyst is in the fourth quarter.
In this article: CRBP
Read
Biogen Ready For A Sizable Bounce
Article By: Bob Lang
Tuesday, June 20, 2017 5:45 PM EDT
The big biopharma company Biogen seems poised for an upside pop soon based on recent turnover and bullish price divergence. It has a good chance to reach the 200 ma for the first time since breaking down in late April.
In this article: BIIB
Read
Becton Dickinson (BDX): A Quality Dividend Aristocrat With Double-Digit Payout Growth
Article By: Simply Safe Dividends
Tuesday, June 20, 2017 3:10 PM EDT
Becton Dickinson is a high quality healthcare company with a number of long-term growth opportunities. Its acquisitions of CareFusion and C.R. Bard significantly expand its addressable market.
In this article: BDX
Read
Axsome Looks Good On Multiple Catalysts: Fast Track Designation Eases Liquidity Concerns
Article By: KKD Healthcare Analytics
Tuesday, June 20, 2017 11:27 AM EDT
Axsome Therapeutics Inc. (AXSM) has multiple catalysts coming up in the near future as it has two main drug candidates under Phase 3 testing for multiple conditions. The stock has shown strength as it gained over 12 percent in the past one month.
In this article: AXSM
Read
Jefferies Sees $60-$75 Per Share Buyout Range For Mallinckrodt
Article By: The Fly
Tuesday, June 20, 2017 10:44 AM EDT
Amid speculation that Mallinckrodt is seeking strategic alternatives, Jefferies analyst Anthony Petrone explored leveraged buyout scenarios in order to gauge the feasibility of a sponsor-led transaction.
In this article: MNK
Read
Parexel To Be Acquired By Pamplona In Transaction Valued At Approximately $5B
Article By: The Fly
Tuesday, June 20, 2017 8:34 AM EDT
Parexel International Corporation and Pamplona Capital Management announced that they have entered into a definitive agreement under which Pamplona will acquire all of the outstanding shares of Parexel for $88.10 per share in cash.
In this article: PRXL
Read
E Best And Worst Large Cap - Tuesday, June 20
Article By: E.B. Capital Markets
Tuesday, June 20, 2017 8:14 AM EDT
The average large cap score is 57 and the average score over the past four weeks is 58.40.
In this article: S, AET, BA, CB, MO, YUM, ABBV, AU, AVP, MAT, MOS, TM
Read
The Top 4 Trading Assets Of The Week - Monday, June 19
Article By: Anyoption
Monday, June 19, 2017 11:51 PM EDT
Overall, the Fed’s activities should be bullish for the USD, but they appear to be bearish. More importantly, the interest-rate hikes have had the opposite effect on gold bullion, causing the precious metal to rise, rather than to fall.
In this article: BAC, FXC, GLD, UUP Also: TVX, AXP, BNO, C, CAT, CVX, JNJ, MS, NKE, WFC, WMT, XOM, BABA
Read
Good Day Today: XBI Breaks Through To YTD Highs
Article By: Rod Raynovich
Monday, June 19, 2017 9:31 PM EDT
Tech stocks rebounded today and biotech stocks soared and maintained the market lead in 2017 performance.
In this article: BMY, ALNY, BMRN, INCY, QQQ, AMGN, CLVS, GILD, XBI, XLV, ICPT, BLUE, RDUS, IBB
Read
Valeant Jumps After Naming Hedge Fund Manager Paulson To Board
Article By: The Fly
Monday, June 19, 2017 11:20 AM EDT
Shares of Valeant Pharmaceuticals popped in early trading after the company announced that activist investor John Paulson, one of its biggest shareholders, will join the board of directors.
In this article: VRX
Read
Biogen Upgraded To Neutral From Sell At UBS
Article By: The Fly
Monday, June 19, 2017 9:21 AM EDT
UBS analyst Carter Gould upgraded Biogen to Neutral and raised his price target for the shares to $270 from $262.
In this article: BIIB
Read
Best Stock Charts - Sunday, June 18
Video By: Robert Desmond
Sunday, June 18, 2017 9:26 PM EDT
We talk about the latest market overview by reviewing different charts.
In this video: GS, HAL, LUB, NUS, AAPL, CLVS, FAS, GLD, IHI, NUGT, USO, XLF, FEYE, PLAY
Watch
ETF Watchlist: Week Of June 19, 2017
Article By: David Dierking
Sunday, June 18, 2017 4:35 PM EDT
The broader S&P 500 (SPY​) was largely unchanged for the week but there were winners and losers if you dug down to the sector level. For the second straight week, tech was a drag on the market.
In this article: QQQ, IHF, XRT, BVAL Also: RTH, XLP, IBUY, FTXD, PNQI, FDN, IGM, IYF, VHT, XLV
Read
Health Care Battle Rages On: Two MedTech Stocks To Buy
Article By: Zacks Investment Research
Saturday, June 17, 2017 7:59 PM EDT
If Obamacare replacement takes place, there is a huge possibility that the Medical Device fraternity will be free from the highly unpopular Cadillac tax (40% excise tax on high-cost healthcare plans) and the controversial 2.3% MedTech tax.
In this article: BIO, PAHC
Read
Medtronic: Why Investors Should Expect This Dividend Aristocrat To Raise Its Dividend Again Soon
Article By: SureDividend
Saturday, June 17, 2017 12:54 PM EDT
Healthcare giant Medtronic, has raised its dividend for an impressive 39 years in a row. Even better, the company has raised its dividend by an average rate of nearly 20% annually, over the course of those 39 years.
In this article: MDT
Read
Rayno Life Science Portfolio 2017
Article By: Rod Raynovich
Saturday, June 17, 2017 11:22 AM EDT
Let's review Rayno Life Science Portfolio for 2017.
In this article: BMY, RHHBY, IBB, QQQ, AMGN, GILD, HOLX, XBI, ABBV, BLUE, FMI
Read
1 to 16 of 4117 Posts
1 2 3 ... 258